Search

Filters

Clear Filters
3:15 PM - 3:20 PM ET

1051 - The ART of SABR: A Randomized Phase II Trial of Near "Margin-less" Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer: Two vs. Five Fractions
Speaker: Waddle, Mark, MD - Mayo Clinic Rochester, Rochester, MN
3:20 PM - 3:25 PM ET

1052 - Results of a Phase 2 Trial of Prostate SBRT with Integrated Tumor Boost and Dose Reduction at Urethra, Bladder and Rectal Interfaces
Speaker: Wilson, Trevor, MD - University of Wisconsin, Madison, WI
3:25 PM - 3:30 PM ET

1053 - Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes
Speaker: Weg, Emily, MD - Weill Cornell Medicine, New York, NY
3:05 PM - 3:10 PM ET

1054 - Ten-Year Outcomes of Elective Upper-Neck vs. Whole-Neck Irradiation for the Uninvolved Neck in Nasopharyngeal Carcinoma Patients with N0-1 or Unilateral N3 Disease and High Pretreatment Plasma Epstein-Barr Virus DNA Load
Speaker: Tang, Linglong, MD, PhD - Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong
3:10 PM - 3:15 PM ET

1055 - A Multicenter, Randomized Controlled Phase III Trial of TPF Induction Chemotherapy vs. PF Adjuvant Chemotherapy Combined with Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: Long-Term Follow-up Analysis
Speaker: Jin, Feng, BS - Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
3:15 PM - 3:20 PM ET

1056 - Evaluating Changes in Tumor Volumes Following Expert Interpretation of Planning Imaging in Head and Neck Cancer Radiotherapy
Speaker: Belliveau, Colin, MD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC
3:20 PM - 3:25 PM ET

1057 - Stereotactic Body Radiotherapy Combined with Chemotherapy and PD-1 Inhibitor in Oligometastatic Nasopharyngeal Carcinoma (STOMP): A Prospective Phase II Clinical Trial
Speaker: Miao, Jingjing, PhD, MS, BS - Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
3:25 PM - 3:30 PM ET

1058 - Similar Overall Survival in Oropharyngeal Cancer Patients Treated with IMRT vs. Proton Therapy
Speaker: Wu, Yingzhi, MSN - Memorial Sloan Kettering Cancer Center, New York, NY
3:30 PM - 3:35 PM ET

1059 - Proton Beam Therapy vs. IMRT for Nasopharyngeal Carcinoma: Differential Late Toxicity Profile at 5 Years
Speaker: Taghizadeh Mortezaei, Nima, MD - Mass General Brigham, Harvard Medical School, Boston, MA
3:10 PM - 3:20 PM ET

106 - Long-Term Follow-up Results for NRG/RTOG 0815: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
Speaker: Krauss, Daniel, MD, FASTRO - Beaumont Health, Royal Oak, MI
3:05 PM - 3:10 PM ET

1060 - A Dynamic Priority-Aware Diffusion Model for Clinically-Driven Dose Prediction in Radiotherapy
Speaker: Yan, Xianrui - Cancer Hospital of Shandong First Medical University, jinan
3:10 PM - 3:15 PM ET

1061 - Adaptive Radiotherapy in Hypersensitive and High Locoregional Risk Breast Cancer: Preliminary Results of the SAHARA04 Phase II Trial
Speaker: Prunaretty, Jessica - Institut du Cancer de Montpellier, Montpellier